baber/WOPTO huggingface dataset:
Patent CA-2532570-A1 (CA)
Inventor: CRANK JUSTIN M
IPC: A61M25/00
Filed: 2004-08-12
Abstract: A medical device (100) includes a coil (110) having a longitudinal axis (x) and a radial axis (y) orthogonal to the longitudinal axis, formed from a wire (305, 400, 500, 600, 700). The wire includes a cross-section (401, 501, 601) with a centroid, a moment of inertia with respect to an axis running through the centroid and parallel to the longitudinal axis of the coil, and a moment of inertia with respect to an axis running through the centroid and parallel to the radial axis of the coil. The moment of inertia with respect to an axis running through the centroid and parallel to the longitudinal axis of the coil is greater than the moment of inertia with respect to an axis running through the centroid and parallel to the radial axis of the coil.
Patent CA-2535067-A1 (CA)
Inventor: NOERENBERG RALF
IPC: C08G18/73
Filed: 2004-08-27
Abstract: The invention relates to a cationic poly(ether-urethane) consisting of a) at least one polyetherol, as constituent A; b) at least one tertiary diol containing amine or ammonium, as constituent B; c) at least one diisocyanate, as constituent C; d) and optionally at least one shortstopping agent, as constituent D; the cationic poly(ether-urethane) having an amine value of between 5 and 40. The invention also relates to a method for producing the inventive cationic poly(ether-urethanes), to compositions containing said cationic poly(ether-urethanes) and at least one anionic surfactant, to a method for foam regulation, especially for the suppression of foam or for defoaming, using at least one inventive cationic poly(ether-urethane), and to the use of said cationic poly(ether-urethane) for foam regulation, especially as a foam suppressing agent or a defoaming agent.
Patent CA-2536671-A1 (CA)
Title: Integrated system for aircraft vortex safety
Inventor: PASEKUNOV IGOR VLADIMIROVICH
IPC: G01S13/93
Filed: 2003-07-25
Abstract: The invention relates to systems for preventing off-normal situations when there is a possibility that an aircraft penetrates into a dangerous area of the vortex shedding of a vortex generator. The inventive system consists of information sub-systems for recording and storing information on the expecte d relative position of the aircraft and trailing vortex areas in line with danger criteria which are specified by a user and concern dangerous aerodynamic forces and torques effecting the aircraft and induced by the trailing vortex of vortex generators, and for conveying said information to said user, who can be the aircraft crew and/or flight attendants, at a preventive distance from the aircraft and at a forecast moment. Said information can be visualised in a human-readable form and in a volume sufficient for forming a directive signal for carrying out a flight manoeuvr e by the aircraft in order to move away from the dangerous trailing vortex are a.
Patent CA-2537091-A1 (CA)
Title: Sampling device with capillary action
Inventor: TROKE JAMES
IPC: G01N1/12
Filed: 2004-08-27
Abstract: The present invention provides a device for receiving a sample of liquid, such as a sample of bodily liquid which is to be subjected to further analysis. The device comprises a body having at least a major surface and a minor surface. A  sample-receiving chamber is located in the body and has an inlet end which opens into the major and minor surfaces of the body. A conduit is located in the body, extends from the outlet end of the chamber, and is arranged so as to allow the liquid to pass from the outlet end into the conduit by capillary action.
Patent CA-2540036-A1 (CA)
Inventor: SIEDLE ALLEN R
IPC: C01B32/942
Filed: 2004-09-23
Abstract: Use of physical vapor deposition methodologies to deposit nanoscale gold on activating support media makes the use of catalytically active gold dramatically easier and opens the door to significant improvements associated with developing, making, and using gold-based, catalytic systems. The present invention, therefore, relates to novel features, ingredients, and formulations of gold-based, heterogeneous catalyst systems generally comprising nanoscale gold deposited onto a nanoporous support.
Patent CA-2540204-A1 (CA)
Title: Dispositif d'administration d'un medicament en poudre dans une fosse nasale
Inventor: TSUTSUI TATSUO
IPC: A61M15/00
Filed: 2003-10-09
Abstract: L'invention concerne un dispositif d'administration de médicament pulvérulent par voie nasale. Selon l'invention, des guides de positionnement (12a, 12b) servant à glisser une capsule (4) vers une position fixe de manière que les dimensions des orifices qui sont pratiqués aux deux extrémités de la capsule (4) soient constantes sont disposés en amont d'éléments de coupe (11a, 11b) conçus pour pratiquer lesdits orifices aux deux extrémités de la capsule (4), laquelle est placée entre une ouverture de connexion d'ajutage (7) qui sert à pulvériser un médicament pulvérulent dans la cavité nasale, et une ouverture de connexion côté pompe (7) qui sert à fournir de l'air de pulvérisation à l'ajutage. Une distance (L) est établie entre les ouvertures de connexion (7) et (8), de manière à être inférieure à la distance (M) qui sépare les extrémités tranchantes desdits éléments de coupe (11a, 11b) (la longueur de la capsule (4) une fois coupée aux deux extrémités par les éléments de coupe (11a, 11b)), pour empêcher la dissipation du médicament pulvérulent se trouvant dans la capsule, par les deux extrémités de ladite capsule (4), qui est placée entre les ouvertures de connexion (7) et (8). En outre, les deux extrémités de la capsule (4), qui est placée entre les ouvertures de connexion (7) et (8), sont pressées par les parties de bord périphérique (14, 15) des ouvertures de connexion (7) et (8).
Patent CA-2543080-A1 (CA)
Inventor: JONES DAVID HUGH
IPC: A61P11/06
Filed: 2004-10-22
Abstract: Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.
Patent CA-2543909-A1 (CA)
Title: High temperature electronic devices
Inventor: MASINO JAMES E
IPC: G01V3/08
Filed: 2004-11-18
Abstract: In at least some embodiments, electronic devices suitable for use at temperatures in excess of 200 ~C may comprise an integrated circuit fabricated on a silicon carbide substrate, and a thick passivation layer. In other embodiments, electronic devices suitable for use at temperatures in excess of 200 ~C may comprise an integrated circuit formed from silicon located on a sapphire substrate, and a thick passivation layer. The electronic devices may be implemented in the context of hydrocarbon drilling and production operations.
Patent CA-2545233-A1 (CA)
Title: Disinfecting compositions and methods of making and using same
Inventor: SCHALLINGER LUKE E
IPC: A61L12/12
Filed: 2004-06-17
Abstract: The present invention provides a composition, comprising: greater than about 0.1% by weight hydrogen peroxide; an aromatic acid component; surfactant;  optionally, a solvent; and a carrier. The composition of the invention is useful as a disinfecting composition for killing microorganisms such as bacterium (including <i>Mycobacterium</i>), spores and fungi. The composition provides a pathogenic bacteria kill rate of 99.9% in about 30 seconds when bacteria are exposed to the composition and is effective in providing a <i>Mycobacterium</i> kill of 106 with two minutes or less. Moreover, the compositions of the invention are generally more resistant to catalase deactivation than, for example, an aqueous solution of hydrogen peroxide. The concentration of hydrogen peroxide within the composition may range from about 1% by weight to about 7% by weight and the concentration of aromatic acid component may range from about 0.1% by weight to about 5% by weight. The invention also provides a method for disinfection of a substrate utilizing the composition. The composition of the invention may be used in the foregoing method on a medical instrument, such as an endoscope or the like. Applying the compositions to a substrate may be accomplished in any of a variety of application methods such as by roll coating, dipping, spraying, or rotational tumbling. The composition may be applied to the substrate for a period of time ranging from about 30 seconds to about ten minutes. In this aspect, the invention can further comprise drying the substrate after removing the composition.
Patent CA-2552303-A1 (CA)
Title: Fixed tiltable antenna device
Inventor: SCHILLING ROBERT
IPC: H01Q1/42
Filed: 2006-07-14
Abstract: An antenna device includes a directional antenna and a support member that supports the antenna. The support member includes one or more fixed supports on which the antenna device can be placed to provide for a desired antenna reception beam elevation angle.
Patent CA-2555773-A1 (CA)
Inventor: IKEUCHI KATSUSHI
IPC: G01S17/89
Filed: 2004-09-15
Abstract: A system for identifying a 3-dimensional shape of an object includes: first measurement means for measuring a first distance and azimuth from a fixed first observation point to a first group of measurement points on the object;  and second measurement means for measuring a second distance and azimuth from a movable second observation point to a second group of measurement points on the object. At least one of the measurement points of the second group is the same as at least one measurement point of the first group and the measurement points of the second group include at least one measurement point not included in the measurement points of the first group. Furthermore, the system includes: calculation means for calculating a movement velocity vector of the second observation point from the measurement result about the same measurement point obtained by the first and the second measurement means, correcting the second measurement result according to the movement velocity vector, and calculating 3-dimensional coordinates of the measurement points of the first and the second group; and display means for displaying an image of the object according to the 3-dimensional coordinates.
Patent CA-2557459-A1 (CA)
Title: Compositions and methods for treating subterranean formations with liquefied petroleum gas
Inventor: FUNKHOUSER GARY P
IPC: E21B43/25
Filed: 2005-02-14
Abstract: The present invention relates to gelled fluids and methods for using liquefied petroleum gas in subterranean operations. More particularly, the present invention relates to servicing fluids that comprise gelled liquefied petroleum gas or servicing fluids that comprise a conventional gelled hydrocarbon fluid with liquefied petroleum gas and methods of using such servicing fluids in subterranean formations. One embodiment of the present invention provides a method of treating a subterranean formation comprising the steps of providing a gelled LPG fluid comprising liquefied petroleurn gas and a gelling agent;  and placing the gelled LPG fluid into the subterranean formation. Another embodiment of the present invention provides a method of treating a subterranean formation comprising the steps of providing a combined LPG  servicing fluid comprising liquefied petroleum gas and a conventional hydrocarbon servicing fluid; and placing the combined LPG servicing fluid into the subterranean formation.
Patent CA-2557496-A1 (CA)
Inventor: STAVNSBJERG RIKKE
IPC: C12N1/20
Filed: 2005-02-24
Abstract: A frozen lactic acid bacteria (LAB) culture in a commercially relevant package that has a weight of at least 50 g frozen material, wherein the frozen material is present in the form of individual pellets characterized by that when stored at -46~C for 7-14 days the individual pellets of the frozen culture are not sticking together and therefore substantially remain as individual pellets.
Patent CA-2557610-A1 (CA)
Inventor: ATKINSON ANTHONY
IPC: A61K38/48
Filed: 2005-02-28
Abstract: A method of combating toxicity caused by an antifolate compound of Formula:  (I), in an individual who has been administered the compound. The method comprises administering an enzyme that has carboxypeptidase G activity to the individual. A method of cleaving a compound comprising a structural fragment of Formula: (VIII), the method comprising contacting the compound comprising the structural fragment of Formula: (VIII) with an enzyme that has carboxypeptidase G activity.
Patent CA-2558702-A1 (CA)
Inventor: LUPSA IOAN LIVIU
IPC: H02G3/12
Filed: 2006-08-30
Abstract: An electrical outlet box for accommodating an electrical fixture comprising a generally rectangular box having a back wall, a perimetrical side wall surrounding said back wall defining an open front face and a box interior, said side wall comprised of a first and second set of generally parallel spaced apart wall portions; and a slidable extension nested within said generally rectangular box, that can be moved from within the generally rectangular box to an extended position beyond the open front face.
Patent CA-2563927-A1 (CA)
Title: Electromagnetic signal emitting and/or receiving device and corresponding integrated circuit
Inventor: MONTANYA SILVESTRE JOSEP
IPC: H01Q3/00
Filed: 2005-05-12
Abstract: Published without an Abstract
Patent CA-2565907-A1 (CA)
Inventor: GEUIJEN CECILIA ANNA WILHELMIN
IPC: C07K16/30
Filed: 2004-05-17
Abstract: The present invention provides a new marker for AML, binding molecules that specifically bind to the new marker, nucleic acid molecules encoding the binding molecules and compositions comprising the binding molecules. The binding molecules capable of specifically binding to the new marker can be used in the diagnosis of AML.
Patent CA-2566360-A1 (CA)
Inventor: SCHLEUSENER MARTIN
IPC: G03G15/09
Filed: 2005-05-09
Abstract: The invention relates to a method and arrangement for inking up an applicator element (14) of an electrophotographic printer or copier. A two-component mixture, which is comprised of electrically charged toner particles and of ferromagnetic particles and which adheres to the outer surface of a roller (16), is moved past a surface of an applicator element (14) to be inked up.  When the two-component mixture is moved past, at least a portion of the toner particles contained in the two-component mixture is transferred to the surface of the applicator element (14) to be inked up. An electrical field is generated that acts at least upon the portion of the two-component mixture located between the surface of the roller (16) and the surface of the applicator element (14) to be inked up. The strength of the electrical field can be controlled with the aid of a control unit so that the transferred toner particles produce a preset layer thickness on the surface to be inked up.
Patent CA-2570255-A1 (CA)
Inventor: HARIHARAN SIVARAMAKRISHNAN
IPC: A61H1/00
Filed: 2005-03-16
Abstract: The present invention relates to compounds cis (Z) and trans (E) stereoisomers of 4-t-butylgapentin of formula (11) and (12) and a process for the preparation of the said stereoisomers.
Patent CA-2570470-A1 (CA)
Title: Medical sensor with modulated encoding scheme
Inventor: VENKATACHALAM K L
IPC: A61B5/145
Filed: 2006-12-15
Abstract: The present invention provides an encoding mechanism for a medical sensor which uses a modulated signal to provide the coded data to a remote analyser.  The modulated signal could be, for instance, a pulse width modulated signal or a frequency modulated signal. This signal is amplitude independent and thus provides a significant amount of noise immunity.
Patent CA-2570649-A1 (CA)
Title: Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
Inventor: KATAGERI SHIVARAJ BASAVARAJ
IPC: A61K47/10
Filed: 2004-06-07
Abstract: Disclosed herein is a pharmaceutical composition comprising a soft gelatin capsule containing a clear and stable solution of sodium dihydratate salt of ibuprofen by employing a system of solubilizer, co-solubilizer and antioxidants.
Patent CA-2572190-A1 (CA)
Title: A method for producing iron oxide nano particles
Inventor: VITNER ASHER
IPC: C01G49/06
Filed: 2005-06-27
Abstract: The invention provides a method for the formation of small-size iron oxide particles comprising the steps of preparing a starting aqueous solution comprising at least one of ferric ions and complexes thereof, at a concentration of at least 0.1% w/w iron and a pH greater than about 1.5;  maintaining said solution at a temperature lower than 55~C for a retention time in which hydrolysis takes place, the extent of said hydrolysis being sufficient to decrease the pH by at least 0.2 units, wherein said time does not exceed 14 days, to form a system containing a modified solution; and adjusting the conditions in said system by at least one of the steps of heating the modified solution to elevate the temperature thereof by at least 10~C; elevating the pH of the modified solution by at least 0.3 units; and diluting the modified solution by at least 20%; whereby there are formed particles, wherein the majority of the particles formed are between about 2nm and about 500nm in size.
Patent CA-2576308-A1 (CA)
Inventor: RAFAT MEHRDAD
IPC: G02B1/00
Filed: 2005-08-12
Abstract: Devices, methods, and compositions for improving vision or treating diseases, disorders or injury of the eye are described. Ophthalmic devices, such as corneal onlays, corneal inlays, and full-thickness corneal implants, are made of a material that is effective in facilitating nerve growth through or over the device. The material may include an amount of collagen greater than 1%  (w/w), such as between about 10% (w/w) and about 30% (w/w). The material may include collagen polymers and/or a second biopolymer or water-soluble synthetic polymer cross-linked using EDC/NHS chemistry. The material may additionally comprise a synthetic polymer. The devices are placed into an eye to correct or improve the vision of an individual or to treat a disease, disorder or injury of an eye of an individual.
Patent CA-2576757-A1 (CA)
Inventor: MAKSEN SMAIL
IPC: B64D45/00
Filed: 2005-07-18
Abstract: The invention concerns a door comprising: an inner structure (16) wherein are provided two compartments; a panel (18) mounted in each of the compartments, and means for maintaining each panel (18) in a corresponding compartment, said means enabling the panel to be released when a predetermined load, in a predetermined direction, is applied on said panel.
Patent CA-2577290-A1 (CA)
Title: Polymeric compositions including their uses and methods of production
Inventor: DATTA SUDHIN
IPC: D04H1/4291
Filed: 2005-07-20
Abstract: Polymeric compositions and methods of making and using such compositions are provided. The compositions incorporate at least one component that is a polymer including propylene-derived units and at least one component that is a styrenic block copolymer. The polymeric compositions are found to have desirable elastomeric properties while at the same time exhibiting beneficial processability characteristics. The unique combination of processability and performance attributes result in the polymeric compositions useful in a variety of applications such as films, fibers, woven and non-woven fabrics, sheets, molded objects, extruded forms, thermoformed objects, and all products made from such application materials.
Patent CA-2578130-A1 (CA)
Title: Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
Inventor: YANG LIYING
IPC: A61K9/107
Filed: 2005-08-26
Abstract: Butylbenzene phthalein Self-emulsifying Drug Delivery System(SEDDS), its preparation method and application. Said SEDDS comprises 1 % - 65 %  butylbenzene phthalein and 10 % - 65 % emulsifier as essential constitutents.  Said SEDDS can be used for the manufacture of various solid or liquid dosage forms (e.g., tablet, soft/hard capsule and others). The present SEDDS can self-emulsify in the gastrointestinal tract, increasing the contact area between the gastrointestinal tract and the drug, and accordingly improving absorptivity of drug.
Patent CA-2581168-A1 (CA)
Title: Methods and apparatus for improving the accuracy and reach of electronic media exposure measurement systems
Inventor: BURKE KAY S
IPC: G06Q50/00
Filed: 2005-07-29
Abstract: Methods and apparatus for crediting media exposure are disclosed. An example method includes deriving a plurality of travel paths (305) traversed by respective ones of a plurality of respondents (102), determining exposures of the respective ones of the plurality of respondents to a plurality of media sites (115) based on the derived plurality of travel paths, and modifying the determined exposures to the plurality of media sites to improve statistical accuracy of the modified determined exposures (397).
Patent CA-2583438-A1 (CA)
Title: Absorbent article with sensation member
Inventor: NISHIKAWA MASAHARU
IPC: A61F13/537
Filed: 2007-03-30
Abstract: An absorbent article having a waist region and a crotch region. The article including a backsheet, an absorbent core, and a sensation member. The absorbent core is disposed between the backsheet and the sensation member. The sensation member forms a portion of a wearer-facing surface of the absorbent article.  The sensation member has a wicking factor of greater than about 20 mm at about one minute, an absorptive capacity of greater than about 0.01 g/cm2, and a capillary pressure of greater than about 50 mm of water.
Patent CA-2585403-A1 (CA)
Inventor: KUNYSZ WALDEMAR
IPC: H01Q1/38
Filed: 2007-04-19
Abstract: An antenna that is suitable for transmission and reception of UWB signals is provided.  The antenna includes a pair of conducting spheres separated by an air gap. A  first conducting sphere is connected to a first conductor of a transmission line and a second conducting sphere is connected to a second conductor of the transmission line.  The dual sphere antenna provides consistent performance in the azimuth plane and across the frequency band for UWB applications.
Patent CA-2585581-A1 (CA)
Title: Enhancing treatment of hif-1 mediated disorders with adenosine a3 receptor agonists
Inventor: MERIGHI STEFANIA
IPC: A61P9/10
Filed: 2005-11-22
Abstract: The present invention relates to the use of adenosine receptor agonists, preferably A3 receptor agonists, either alone or in combination with other agents for the treatment, prevention and/or management of diseases or disorders associated with under~expression of HIF-1 .alpha. and/or decreased HIF-1 .alpha.activity (e.g., ischemic related disorders). The methods of the invention are directed to methods of reducing tissue damage (e.g., substantially preventing tissue damage, inducing tissue protection) resulting from ischemia orhypoxia. The invention provides methods for treating, preventing and/or ameliorating one or more symptoms of hypoxic or HIF-la related disorders by administering an A3 receptor agonist either alone or in combination with other agents.